Hua-Jay J Cherng

14PUBLICATIONS
120CO-AUTHORS
Liquid biopsiesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAfrican languages
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Jun 07, 2026
Treatment intensity, illness burden, and disparities in newly diagnosed diffuse large B-cell lymphoma treated at an urban academic center.

|Jan 06, 2026
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma.

Juan Pablo Alderuccio, Diva Baggio, Sunwoo Han

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Aug 13, 2025
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.

Mark Roschewski, David M Kurtz, Jason R Westin

|Apr 14, 2025
Measurable Residual Disease Testing During Treatment with Bispecific Antibodies for Lymphoma.

Gaston Jean-Louis, Hua-Jay J Cherng

Pageof 3

Frequent Collaborators

6 joint publications

Jason Westin

3 joint publications

Joanna M Rhodes

2 joint publications

Koji Sasaki

2 joint publications

Sairah Ahmed